Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2015-06-11 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BORDEAUX (33000), Gironde
PHARMACIE PAUL DOUMER : revenue, balance sheet and financial ratios
PHARMACIE PAUL DOUMER is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BORDEAUX (33000),
this company of category PME
shows in 2023 a revenue of 3.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE PAUL DOUMER (SIREN 811954791)
Indicator
2025
2024
2023
2022
2017
2016
Revenue
N/C
N/C
3 184 628 €
N/C
1 927 678 €
1 832 887 €
Net income
254 044 €
5 698 €
53 344 €
258 388 €
118 905 €
30 426 €
EBITDA
N/C
N/C
87 461 €
N/C
186 989 €
37 359 €
Net margin
N/C
N/C
1.7%
N/C
6.2%
1.7%
Revenue and income statement
In 2025, PHARMACIE PAUL DOUMER generates positive net income of 254 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 30 k€ -> 254 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
254 044 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 638%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 12%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
638.297%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
11.515%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE PAUL DOUMER
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2022
2023
2024
2025
Debt ratio
1088.735
547.945
231.283
190.087
1498.19
638.297
Financial autonomy
7.576
13.623
25.892
29.42
5.412
11.515
Repayment capacity
46.556
10.412
None
22.946
None
None
Cash flow / Revenue
1.664%
6.803%
None%
2.073%
None%
None%
Sector positioning
Debt ratio
638.32025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Watch
In 2025, the debt ratio of PHARMACIE PAUL DOUMER (638.30) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Financial autonomy
11.52%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Watch
In 2025, the financial autonomy of PHARMACIE PAUL DOUMER (11.5%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
22.95 years2023
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Watch
In 2023, the repayment capacity of PHARMACIE PAUL DOUMER (22.95) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 159.18. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
159.178
Liquidity indicators evolution PHARMACIE PAUL DOUMER
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2022
2023
2024
2025
Liquidity ratio
154.287
149.172
135.339
94.938
155.218
159.178
Interest coverage
43.663
8.178
None
6.437
None
None
Sector positioning
Liquidity ratio
159.182025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average+21 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE PAUL DOUMER (159.18) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
6.44x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Good
In 2023, the interest coverage of PHARMACIE PAUL DOUMER (6.4x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 95 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 698 days. Excellent situation: suppliers finance 603 days of the operating cycle (retail model).
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
95 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
698 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE PAUL DOUMER
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2022
2023
2024
2025
Operating WCR
161 312 €
185 231 €
0 €
215 185 €
0 €
0 €
Inventory turnover (days)
29
41
0
31
0
0
Customer payment term (days)
10
6
0
4
115
95
Supplier payment term (days)
25
28
0
38
618
698
Positioning of PHARMACIE PAUL DOUMER in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE PAUL DOUMER is estimated at
4 035 519 €
(range 2 738 522€ - 6 332 285€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
2738k€4035k€6332k€
4 035 519 €Range: 2 738 522€ - 6 332 285€
NAF 5 année 2025
Valuation method used
Net Income Multiple
254 044 €
×
15.9x
=4 035 519 €
Range: 2 738 522€ - 6 332 285€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE PAUL DOUMER with other companies in the same sector:
Frequently asked questions about PHARMACIE PAUL DOUMER
What is the revenue of PHARMACIE PAUL DOUMER ?
The revenue of PHARMACIE PAUL DOUMER in 2023 is 3.2 M€.
Is PHARMACIE PAUL DOUMER profitable?
Yes, PHARMACIE PAUL DOUMER generated a net profit of 254 k€ in 2025.
Where is the headquarters of PHARMACIE PAUL DOUMER ?
The headquarters of PHARMACIE PAUL DOUMER is located in BORDEAUX (33000), in the department Gironde.
Where to find the tax return of PHARMACIE PAUL DOUMER ?
The tax return of PHARMACIE PAUL DOUMER is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE PAUL DOUMER operate?
PHARMACIE PAUL DOUMER operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart